Postoperative Lumbar Fusion Bone Morphogenic Protein–Related Epidural Cyst Formation

References

1. 1.↵
   1. Urist MR

   . Bone: formation by autoinduction. Science 1965;150:893–99 doi:10.1126/science.150.3698.893 pmid:5319761

   Abstract/FREE Full Text
2. 2.↵
   1. Kerezoudis P,
   2. Alvi MA,
   3. Freedman BA, et al

   . Utilization trends of recombinant human bone morphogenetic protein in the United States. Spine (Phila Pa 1976) 2021;46:874–81 doi:10.1097/BRS.0000000000003919 pmid:33395021

   CrossRefPubMed
3. 3.↵
   1. Wu Z,
   2. Zhou B,
   3. Chen L, et al

   . Bone morphogenetic protein-2 against iliac crest bone graft for the posterolateral fusion of the lumbar spine: a meta-analysis. Int J Clin Pract 2021;75:e13911 doi:10.1111/ijcp.13911 pmid:33277737

   CrossRefPubMed
4. 4.↵
   1. Liu S,
   2. Wang Y,
   3. Liang Z, et al

   . Comparative clinical effectiveness and safety of bone morphogenetic protein versus autologous iliac crest bone graft in lumbar fusion: a meta-analysis and systematic review. Spine (Phila Pa 1976) 2020;45:E729–41 doi:10.1097/BRS.0000000000003372 pmid:31923133

   CrossRefPubMed
5. 5.↵
   1. Guzman JZ,
   2. Merrill RK,
   3. Kim JS, et al

   . Bone morphogenetic protein use in spine surgery in the United States: how have we responded to the warnings? Spine J 2017;17:1247–54 doi:10.1016/j.spinee.2017.04.030 pmid:28456674

   CrossRefPubMed
6. 6.↵
   1. Carragee EJ,
   2. Hurwitz EL,
   3. Weiner BK

   . A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 2011;11:471–91 doi:10.1016/j.spinee.2011.04.023 pmid:21729796

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Zara JN,
   2. Siu RK,
   3. Zhang X, et al

   . High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A 2011;17:1389–99 doi:10.1089/ten.TEA.2010.0555 pmid:21247344

   CrossRefPubMed
8. 8.↵
   1. Shields LB,
   2. Raque GH,
   3. Glassman SD, et al

   . Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976) 2006;31:542–47 doi:10.1097/01.brs.0000201424.27509.72 pmid:16508549

   CrossRefPubMed
9. 9.↵
   1. Dietz N,
   2. Sharma M,
   3. Kelly M, et al

   . Recombinant human bone morphogenetic protein-2 use in adult spinal deformity surgery: comparative analysis and healthcare utilization at 24 months’ follow-up. Global Spine J 2022;12:92–101 doi:10.1177/2192568220947377 pmid:32844671

   CrossRefPubMed
10. 10.↵
    1. Nguyen V,
    2. Meyers CA,
    3. Yan N, et al

    . BMP-2-induced bone formation and neural inflammation. J Orthop 2017;14:252–56 doi:10.1016/j.jor.2017.03.003 pmid:28367006

    CrossRefPubMed
11. 11.↵
    1. Lee KB,
    2. Taghavi CE,
    3. Murray SS, et al

    . BMP induced inflammation: a comparison of rhBMP-7 and rhBMP-2. J Orthop Res 2012;30:1985–94 doi:10.1002/jor.22160 pmid:22674456

    CrossRefPubMed
12. 12.↵
    1. Mannion RJ,
    2. Nowitzke AM,
    3. Wood MJ

    . Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2: but what is the cost? Spine J 2011;11:527–33 doi:10.1016/j.spinee.2010.07.005 pmid:20739225

    CrossRefPubMed
13. 13.↵
    1. Baron EM,
    2. Mejía DM,
    3. Drazin D, et al

    . Postoperative cyst associated with bone morphogenetic protein use in posterior and transforaminal lumbar interbody fusion managed conservatively: report of two cases. Cureus 2016;8:e485 doi:10.7759/cureus.485 pmid:27014519

    CrossRefPubMed
14. 14.↵
    1. Choudhry OJ,
    2. Christiano LD,
    3. Singh R, et al

    . Bone morphogenetic protein-induced inflammatory cyst formation after lumbar fusion causing nerve root compression. J Neurosurg Spine 2012;16:296–301 doi:10.3171/2011.11.SPINE11629 pmid:22176433

    CrossRefPubMed
15. 15.↵
    1. Sethi A,
    2. Craig J,
    3. Bartol S, et al

    . Radiographic and CT evaluation of recombinant human bone morphogenetic protein-2–assisted spinal interbody fusion. AJR Am J Roentgenol 2011;197:W128–33 doi:10.2214/AJR.10.5484 pmid:21700973

    CrossRefPubMed
16. 16.↵
    1. Bordukalo-Nikšić T,
    2. Kufner V,
    3. Vukičević S

    . The role of BMPs in the regulation of osteoclasts resorption and bone remodeling: from experimental models to clinical applications. Front Immunol 2022;13:869422 doi:10.3389/fimmu.2022.869422 pmid:35558080

    CrossRefPubMed
17. 17.↵
    1. Haid RW,
    2. Branch CL,
    3. Alexander JT, et al

    . Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J 2004;4:527–38 doi:10.1016/j.spinee.2004.03.025 pmid:15363423

    CrossRefPubMed
18. 18.↵
    1. Chrastil J,
    2. Low JB,
    3. Whang PG, et al

    . Complications associated with the use of the recombinant human bone morphogenetic proteins for posterior interbody fusions of the lumbar spine. Spine (Phila Pa 1976) 2013;38:E1020–27 doi:10.1097/BRS.0b013e3182982f8e pmid:23629484

    CrossRefPubMed
19. 19.↵
    1. Mobbs RJ,
    2. Phan K,
    3. Malham G, et al

    . Lumbar interbody fusion: techniques, indications and comparison of interbody fusion options including PLIF, TLIF, MI-TLIF, OLIF/ATP. J Spine Surg 2015;1:2–18 pmid:27683674

    PubMed